There are no products listed under this category.
MBNL3
MBNL3 (muscleblind like splicing regulator 3, also known as CHCR, MBXL and MBLX39) is a member of the muscleblind family of CCCH-type zinc finger proteins. It regulates pre-mRNA alternative splicing and may contribute to the pathophysiology of myotonic dystrophy. Browse Assay Genie's current range of MBNL3 research reagents below, or read on for the biology behind the target.
MBNL3 mediates the regulation of pre-mRNA alternative splicing. It can act as either an activator or a repressor of splicing, depending on the specific pre-mRNA target. In muscle, the MBNL3 protein inhibits inclusion of the exon in cardiac troponin-T (TNNT2) pre-mRNA, but promotes exon inclusion in insulin receptor (IR) pre-mRNA. It also antagonises the alternative splicing activity pattern of CELF proteins, so the two groups of regulators work in opposition.
The MBNL3 gene encodes a protein that belongs to the muscleblind family and is classed by HGNC among the CCCH-type zinc fingers and the muscleblind like splicing regulator family. UniProt records the protein in both the nucleus and the cytoplasm. The NCBI Gene summary notes that alternatively spliced transcript variants have been described. The mouse ortholog is Mbnl3, and MBNL1 is a related member of the same family.
The symbol reflects the gene's history: earlier names include muscleblind-like 3 (Drosophila), and aliases include CHCR, FLJ11316, MBLX39 and MBXL. Functionally, MBNL3 may play a role in myotonic dystrophy (DM) pathophysiology. It could also inhibit terminal muscle differentiation, acting at approximately the time of myogenin induction. This makes it a useful subject for work on splicing control in muscle and on the molecular basis of DM.
MBNL3 acts as an activator or repressor of splicing on specific pre-mRNA targets, making it a model for context-dependent splicing control.
MBNL3 may play a role in the pathophysiology of myotonic dystrophy, so it is relevant to investigations of DM mechanisms.
MBNL3 could inhibit terminal muscle differentiation at about the time of myogenin induction, linking splicing regulation to myogenesis.
MBNL3 opposes the splicing activity pattern of CELF proteins and affects TNNT2 and insulin receptor exon inclusion in muscle.
MBNL3 regulates pre-mRNA alternative splicing, acting as an activator or repressor depending on the target. It inhibits TNNT2 exon inclusion but induces insulin receptor exon inclusion in muscle, and it antagonises CELF protein splicing activity. It may also inhibit terminal muscle differentiation.
MBNL3 is the HGNC symbol for muscleblind like splicing regulator 3. Aliases include CHCR, FLJ11316, MBLX39 and MBXL, and previous names include muscleblind-like 3 (Drosophila). UniProt lists the protein as Muscleblind-like protein 3. Alternatively spliced transcript variants have been described.
UniProt and NCBI Gene both state that MBNL3 may play a role in myotonic dystrophy pathophysiology. A mouse ortholog, Mbnl3, exists. Check the datasheet of any product for its validated reactivity.
MBNL1, another muscleblind family splicing regulator with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9NUK0; product specifications from Assay Genie datasheets.
There are no products listed under this category.